Immediate and enduring value for organizations across the healthcare landscape.
Reduce ED by 26% and IP by 17%1
For members with type 2 diabetes compared to the control group. This yields cost savings from $2,750-$6,300 per engaged member per year.
150+ exchanges on average between member and care team
Our care team delivers unparalleled engagement, with members reporting 4.8/5 satisfaction and ~20% more exchanges among older members.
Improve clinical outcomes with a 1.8% reduction in HbA1c for members with A1c > 9
Clients see improved clinical measures across multiple conditions in 3 months. There’s no faster way to improved outcomes & cost savings.
Impact 8+ quality metrics
We drive real clinical impact for HEDIS measures & Star Ratings for a range of chronic conditions, disease management, refill rates, and prevention measures.
Get real-time adherence data
With our program, sponsors, CROs, and clinical trial sites can evaluate adherence (compliance) rates earlier, in real-time, and more accurately to increase successful, cost-efficient clinical trials.
Directly observe 100% of doses
We directly observe 100% of submitted doses using asynchronous video technology — allowing for more accurate efficacy estimates and improved patient support.
Improve patient retention
Our patient-friendly technology and service increase patient understanding of the dosing protocol, keep patients engaged, and reduce barriers to trial participation.
Increase cost efficiency/Reduce Site Burden
Scene offers white-glove support to ensure smooth execution and high-quality data while speeding up trial completion. Our flexible approach accommodates various study protocols and administration methods—whether orals, inhalers, topicals, or injections. Scene delivers reliable, on-time, and cost-effective trial completion without adding an unnecessary burden on the sites.
Secure up to 100% adherence rates2
Medication adherence with our video Directly Observed Therapy (DOT) program is comparable to that of in-person DOT and provides a higher percentage of administered treatment doses.
Save $1,400 per patient3
We help public health departments achieve significant time and cost savings compared with in-person DOT treatments due to reduced employee hours and driving costs.
Expand capacity
Our platform extends limited resources by removing in-person dosing requirements and offering multiple modalities for DOT (asynchronous, livestream & in-person appointments). We also provide Video Review as a Service to further maximize available resources.
Make meaningful, remote care easy
Our flexible, convenient, and easy-to-use app is available in 20+ languages and was built to support low-resource settings.
Reduce readmissions and ED visits
Better coordination and communication tools support patients and encourage adherence at each step, reducing rates of hospital readmission and ED visits.
Improve adherence and administration technique
When patients take their medications properly and improve true medication adherence, they improve health outcomes like A1c values and blood pressure control fast.
Strengthen patient engagement
Our high-touch program allows our care team to connect with patients every day to ensure that no medication adherence issues fall through the cracks.
Gather SDOH data
We successfully identify and help patients overcome root causes of nonadherence with extensive support for issues related to Social Determinants/Drivers of Health (SDOH).
At Scene, we meet patients where they are—every day—to build trusted relationships and empower lasting change.
Empowering patients to take control of their condition and take their medication properly delivers unparalleled clinical outcomes.
25+ Peer-reviewed Publications
We offer one of the most comprehensive collections of peer-reviewed research in the field of medication adherence. With over 25 publications, our studies demonstrate how our approach to MedEngagement boosts true medication adherence, the fastest way to improve health.
References
- Improvement in utilization for an emerging and high risk population of members with diabetes. Analysis performed by a medical economics team of a large national Medicaid MCO. Cost savings & reduction in ED/IP visits represent impact on Scene engaged members compared to unengaged population.
- Morris, S., Miner, M., Rodriguez, T., Stancil, R., Wiltz-Beckham, D., & Chorba, T. (2017). Notes from the field: Tuberculosis control activities after Hurricane Harvey — Texas, 2017. MMWR Morbidity and Mortality Weekly Report, 66(49), 1362–1363. http://dx.doi.org/10.15585/mmwr.mm6649a5
- Holzman, S. B., Zenilman, A., & Shah, M. (2018). Advancing patient-centered care in tuberculosis management: A mixed-methods appraisal of video directly observed therapy. Open Forum Infectious Diseases, 5(4), ofy046. https://doi.org/10.1093/ofid/ofy046
- McIntire, K., Weis, B., Litwin Ye, L., & Krugman, S. D. (2022). Feasibility of video observed therapy to support controller inhaler use among children in West Baltimore. The Journal of asthma : official journal of the Association for the Care of Asthma, 59(10), 1961–1972. https://doi.org/10.1080/02770903.2021.1984525
- Litwin, A. H., Lum, P. J., Taylor, L. E., Mehta, S. H., Tsui, J. I., Feinberg, J., Kim, A. Y., Norton, B. L., Heo, M., Arnsten, J., Meissner, P., Karasz, A., Mckee, M. D., Ward, J. W., Johnson, N., Pericot-Valverde, I., Agyemang, L., Stein, E. S., Thomas, A., Borsuk, C., … HERO Study Group (2022). Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial. The lancet. Gastroenterology & hepatology, 7(12), 1112–1127. https://doi.org/10.1016/S2468-1253(22)00275-8
- Hallgren, K. A., Darnton, J., Soth, S., Blalock, K. L., Michaels, A., Grekin, P., Saxon, A. J., Woolworth, S., & Tsui, J. I. (2022). Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic. Journal of substance abuse treatment, 143, 108896. https://doi.org/10.1016/j.jsat.2022.108896
- Creary, S., Chisolm, D., Stanek, J., et al. (2020). Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease. Pediatric Blood & Cancer, 67, e28250. https://doi.org/10.1002/pbc.28250
- Creary, S., Chisolm, D., Stanek, J., Hankins, J., & O'Brien, S. H. (2019). A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study. JMIR mHealth and uHealth, 7(8), e13452. https://doi.org/10.2196/13452
- Killian, M. O., Clifford, S., Lustria, M. L. A., Skivington, G. L., & Gupta, D. (2022). Directly observed therapy to promote medication adherence in adolescent heart transplant recipients. Pediatric transplantation, 26(5), e14288. https://doi.org/10.1111/petr.14288
- Scene Health. (2023). Case Study: Improving Hypertension Outcomes with a Medicaid Health Plan. Scene Health. Retrieved from https://insights.scene.health/hubfs/Scene%20Public/Case%20Studies/Health%20Plans/Scene%20-%20Health%20Plan%20Case%20Study%20-%20Hypertension.pdf
- Perry, A., Chitnis, A., Chin, A., Hoffmann, C., Chang, L., Robinson, M., Maltas, G., Munk, E., & Shah, M. (2021). Real-world implementation of video-observed therapy in an urban TB program in the United States. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 25(8), 655–661. https://doi.org/10.5588/ijtld.21.0170
- Holzman, S. B., Zenilman, A., & Shah, M. (2018). Advancing Patient-Centered Care in Tuberculosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy. Open forum infectious diseases, 5(4), ofy046. https://doi.org/10.1093/ofid/ofy046
- Scene Health. (2022). Emocha Health Rx Healthy Living Flip The ScriptHIV Program Adherence Services Program Review. Scene Health.